Objectively measured breast symmetry has no influence on quality of life in breast cancer patients
Objectively measured breast symmetry has no influence on quality of life in breast cancer patients
复制标题
DOI：
10.1016/j.ejso.2011.10.012
复制
发表时间：
2012-02-01
期刊：
影响因子：
3.8
通讯作者：
Fitzal, F.
中科院分区：
文献类型：
--
作者：
Exner, R.;Krois, W.;Fitzal, F.
目的：探讨乳腺癌患者的生活质量与乳房对称性的关系。方法：采用乳腺分析工具(BAT)对101例乳腺癌保乳术患者术后不同时间点的乳房对称性进行客观测量。我们将结果与同时使用乳房成像量表(BIS)、EORTC QLQ-BR23量表和未经验证的性行为评分量表测量的生活质量相关联。年龄、肿瘤大小、肿瘤/乳房关系和肿瘤整形手术的使用也与对称性和生活质量量表相关。结果：平均年龄56岁(11.6岁)，75.2%的患者有T1或T2肿瘤。患者年龄(p=0.03)和肿瘤大小(p=0.01)显著影响客观测量的乳房对称性。对于53%的患者来说，美容效果很重要，而48%的患者认为它不重要。结论：乳腺癌手术后，乳房对称性不是影响患者生活质量和乳房自尊的主要因素。在乳腺癌患者中，美容效果似乎不如肿瘤结果那么重要。(C)2011爱思唯尔有限公司。保留所有权利。
Aims: This study investigates how quality of life (QoL) of breast cancer patients is related to breast symmetry.Methods: We objectively measured breast symmetry using the breast analyzing tool (BAT) in 101 patients after breast conserving surgery for breast cancer at different time points during follow up. We correlated the results with the quality of life measured at the same time using the breast image scale (BIS), the EORTC QLQ-BR23 scale and a not validated sexual score scale. Age, tumour size, tumour/breast relation and the use of oncoplastic surgery were also correlated with symmetry and quality of life scales. Using multivariate analyses, independent parameters for an improved quality of life were identified.Results: Mean age was 56 ( 11.6), and 75.2% of patients had T1 or T2 tumours. Patient age (p = 0.03) and tumour size (p = 0.01) significantly influenced objectively measured breast symmetry. The cosmetic result was important for 53% of patients while 48% found it not important. Independent from this, neither overall quality of life nor breast self esteem was influenced by breast symmetry in our patients.Conclusions: After breast cancer surgery, breast symmetry is not a major factor for patients' quality of life and breast self esteem. Cosmetic result seems to be less important than oncologic outcome in patients with breast cancer. (C) 2011 Elsevier Ltd. All rights reserved.